Mehmet Oz, the head of the Centers for Medicare & Medicaid Services (CMS), says “there are going to be consequences” as more Americans choose marijuana over alcohol—including problems caused by “high-dose hemp and CBD.”
As the Trump administration works to finalize a cannabis rescheduling proposal and prepares to roll out a CBD coverage plan through Medicare under Oz’s agency, the health official curiously raised concerns about non-intoxicating cannabidiol and hemp products overall.
During an interview with Katie Miller—the wife of top Trump advisor Stephen Miller—Oz was asked whether shifts in consumer preferences away from alcohol and toward cannabis pose any risks. And the CMS administrator answered affirmatively.
“Anything that’s strong enough to help you is strong enough to hurt you. So yes, there are going to be consequences,” he said. “We already know that some of the high-dose hemp and CBD is a problem.”
The comments are especially notable given that Oz is leading an initiative tied to the marijuana rescheduling executive order President Donald Trump issued in December that’s meant to incorporate CBD coverage under federal health care programs. The health official has made multiple statements over recent years supporting the therapeutic use of marijuana and its constituents.
Read full article on Marijuana Moment
